MHC Class II-Restricted Epitopes Containing an Oxidoreductase Activity Prompt CD4(+) T Cells with Apoptosis-Inducing Properties.

Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model. Front Immunol (2016) 0.75

Cytotoxic CD4 T Cells-Friend or Foe during Viral Infection? Front Immunol (2017) 0.75

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med (2006) 14.33

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60

Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med (2002) 3.80

Characterization of CD4(+) CTLs ex vivo. J Immunol (2002) 3.10

CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68

CD4+ T-cell memory: generation and multi-faceted roles for CD4+ T cells in protective immunity to influenza. Immunol Rev (2006) 2.49

Allosteric disulfide bonds. Biochemistry (2006) 2.32

Thioredoxins and glutaredoxins: unifying elements in redox biology. Annu Rev Genet (2009) 2.27

Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol (2003) 1.87

Regulatory T-cell therapy: is it ready for the clinic? Nat Rev Immunol (2005) 1.76

Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. Cell Immunol (2010) 1.69

Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev (1995) 1.66

Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins. J Exp Med (2006) 1.57

CD4+ cytolytic T cell clone confers protection against murine malaria. J Exp Med (1990) 1.51

Acquisition of specific cytotoxic activity by human T4+ T lymphocytes in culture. Nature (1984) 1.48

Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines (2010) 1.47

Selective redox regulation of cytokine receptor signaling by extracellular thioredoxin-1. EMBO J (2007) 1.46

CD4+CD25+ T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J Immunol (2003) 1.42

T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity (1997) 1.40

Cellular immunity and memory to respiratory virus infections. Immunol Res (2001) 1.38

T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med (2005) 1.24

HLA-D region-associated determinants serve as targets for human cell-mediated lysis. J Exp Med (1979) 1.22

Functional and molecular comparison of anergic and regulatory T lymphocytes. J Immunol (2006) 1.17

Low-strength T-cell activation promotes Th17 responses. Blood (2010) 1.15

Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex. J Immunol (2006) 1.09

The power and the promise of restimulation-induced cell death in human immune diseases. Immunol Rev (2010) 1.09

Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur J Immunol (2006) 1.07

Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J Autoimmun (2012) 1.01

Low doses of interleukin 2 induce bystander cell lysis by antigen-specific CD4+ inflammatory T cell clones in short-term assay. Eur J Immunol (1988) 0.94

Vaccine against autoimmune disease: antigen-specific immunotherapy. Curr Opin Immunol (2013) 0.94

CD4 CTL: living up to the challenge. Semin Immunol (2013) 0.93

Re-Directing CD4(+) T Cell Responses with the Flanking Residues of MHC Class II-Bound Peptides: The Core is Not Enough. Front Immunol (2013) 0.84

Autoantigen based vaccines for type 1 diabetes. Discov Med (2011) 0.81

The Dermatophagoides pteronyssinus group 2 allergen contains a universally immunogenic T cell epitope. J Immunol (2002) 0.79

Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors. PLoS One (2012) 0.78

The hidden truth about gene expression in Tregs: is it what you don't see that counts? Eur J Immunol (2006) 0.78